Single low-dose ketamine infusion for women with prenatal depressive symptoms undergoing cesarean delivery: A pilot randomized trial

BACKGROUND: Ketamine is approved for antidepressant therapy, but evidence regarding its use in women with perinatal depression is lacking. Herein, we investigated the effects of low-dose ketamine in women with prenatal depressive symptoms and tested the feasibility of a future large randomized trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuo, Deng, Chun-Mei, Zeng, Yuan, Ma, Jia-Hui, Qu, Yuan, Wang, Dong-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774481/
https://www.ncbi.nlm.nih.gov/pubmed/36570810
http://dx.doi.org/10.3389/fsurg.2022.1050232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774481/
https://www.ncbi.nlm.nih.gov/pubmed/36570810
http://dx.doi.org/10.3389/fsurg.2022.1050232

Ejemplares similares